or
forgot password
  • cancer clinical trials in mississippi

  • Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Endometrial Cancer
    Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Sarcoma
    MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer
    North Mississippi Hematology & Oncology Associates, Ltd.
    Tupelo, Mississippi 38801
    Prostate Cancer
    Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    University of Mississippi Medical Center

    Trial Locations
    University of Mississippi Medical Center
    Keesler Medical Center - Keesler Air Force Base
    Pancreatic Cancer
    FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer
    University of Mississippi Medical Center

    Trial Locations
    University of Mississippi Medical Center
    Veterans Affairs Medical Center - Jackson
    Colorectal Cancer
    TraumeelĀ® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Kidney Cancer, Leukemia, Lymphoma, Neuroblastoma, Oral Complications, Sarcoma
    hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Neuroblastoma
    Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Leukemia
    SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma
    Pfizer Investigational Site
    Olive Branch, Mississippi 38654
    Carcinoma, Renal Cell
    Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer

    Jackson, Mississippi
    Breast Neoplasms, Neoplasm Metastasis
    S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Head and Neck Cancer
    Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary CNS Germ Cell Tumor
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Brain Tumor, Central Nervous System Tumor
    Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
    University of Mississippi Medical Center

    Trial Locations
    University of Mississippi Medical Center
    Keesler Medical Center - Keesler Air Force Base
    Endometrial Cancer
    Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    University of Mississippi Medical Center

    Trial Locations
    University of Mississippi Medical Center
    Keesler Medical Center - Keesler Air Force Base
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Cervical Cancer
    S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Lung Cancer, Pulmonary Complications
    Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Epratuzumab and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Recurrent Childhood Acute Lymphoblastic Leukemia
    Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer
    Hattiesburg Clinic Oncology
    Hattiesburg, Mississippi 39401
    Pancreatic Cancer
    S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Head and Neck Cancer
    Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Brain and Central Nervous System Tumors
    Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Cervical Cancer
    SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy
    GSK Investigational Site
    Hattiesburg, Mississippi 39401
    Thrombocytopenia, Thrombocytopaenia
    Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy
    GSK Investigational Site
    Hattiesburg, Mississippi 39401
    Nausea and Vomiting, Chemotherapy-Induced, Chemotherapy-Induced Nausea and Vomiting
    Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Brain and Central Nervous System Tumors
    Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Sarcoma
    Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer
    N. Mississippi Hematology & Oncology Associates
    Tupelo, Mississippi 38801
    Pancreatic Cancer
    Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Sarcoma
    Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma
    Pfizer Investigational Site
    Olive Branch, Mississippi 38654
    Carcinoma, Renal Cell
    Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer
    Pfizer Investigational Site
    Olive Branch, Mississippi 38654
    Carcinoma, Non-Small-Cell Lung
    A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Tupelo, Mississippi
    Colorectal Cancer
    Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer
    Jackson Oncology Associates
    Jackson, Mississippi 39202
    Colon Cancer
    Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site
    Jackson Oncology Associates
    Jackson, Mississippi 39202
    Neoplasms, Unknown Primary
    Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease
    Site Ref # / Investigator 1832
    Jackson, Mississippi 39202
    Crohn's Disease
    A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients
    Duramed Investigational Site
    Jackson, Mississippi 39202
    Prostate Cancer
    Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women
    Pfizer Investigational Site
    Olive Branch, Mississippi 38654
    Osteoporosis
    Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Thalassemia, Sickle Cell Disease, Diamond Blackfan Anemia, Myelofibrosis
    Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer
    Pfizer Investigational Site
    Olive Branch, Mississippi 38654
    Breast Neoplasms
    Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer
    Pfizer Investigational Site
    Olive Branch, Mississippi 38654
    Breast Neoplasms
    Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Olive Branch, Mississippi 38654
    Carcinoma, Non-Small-Cell Lung
    A Long-term Safety Study of Infliximab (Remicade)

    Jackson, Mississippi
    Arthritis, Rheumatoid, Crohn Disease, Psoriasis
    Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
    The West Clinic
    Corinth, Mississippi 38834
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Head and Neck Cancer
    Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Lung Cancer
    A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin
    North Missssppi Hematology Oncology Associates
    Tupelo, Mississippi 38801
    Diffuse Large-Cell Lymphoma
    Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Stage I Lymphoepithelioma of the Nasopharynx, Stage I Squamous Cell Carcinoma of the Nasopharynx, Stage II Lymphoepithelioma of the Nasopharynx, Stage II Squamous Cell Carcinoma of the Nasopharynx, Stage III Lymphoepithelioma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx